May 25th, 2010
Innoventus closes deal regarding new innovative system for urine catheters
Dec 8th, 2009
Innoventus Project AB tecknar avtal med amerikanskt bioteknikföretag.
Nov 24th, 2009
Innoventus Project AB appoints Malin Graffner Nordberg as CEO
Dec 9th, 2008
Fluoroscerande proteiner handlar inte bara om årets Nobelpris i kemi utan är även ett område för framgångsrik forskning i Uppsala. Läs pressmeddelande.
Jan 22nd, 2008
Innoventus Project AB’s periodontitis project enters Phase I. Read press release
Innoventus invests in early-stage
life science and biotech projects
We work in the phase where technology ventures are too immature to meet traditional investment criteria.
Our mission is to develop novel technology concepts and transform them into objects of visible and measurable commercial value.
Our exit strategy is to attract industrial and venture capital.
Our unique approach of 'hands-on' management plus the necessary capital resources ensures cost-effective and speedy critical early-stage development.
Review our success factors to see what we can offer you.
life science and biotech projects
We work in the phase where technology ventures are too immature to meet traditional investment criteria.
Our mission is to develop novel technology concepts and transform them into objects of visible and measurable commercial value.
Our exit strategy is to attract industrial and venture capital.
Our unique approach of 'hands-on' management plus the necessary capital resources ensures cost-effective and speedy critical early-stage development.
Review our success factors to see what we can offer you.
Innoventus follows a well-planned and proven strategy for transforming bioscience innovations into successful product launches.
Idea evaluation/project acceptance
Innoventus team members review your project proposal to determine if it meets our criteria. If we think we can develop it further, we accept your project
Project agreement
Together, we develop an agreement outlining a project development plan (including budget, time-lines and project milestones), and agree terms for future revenue sharing.
Proof of concept
This stage involves research and development activities, functional prototypes in technology projects, in vitro and animal studies, and other preclinical trials to generate data proving hypotheses and product concepts.
Product development
Strategic partnerships provide resources for lead identification (drug discovery), Phase I and II drug studies, production start-up, regulatory approval, and possibly market incubation or introduction.
Commercialisation
The end-phase of the product development cycle may include licensing to industry, sale of IP to industry, sale of intermediate company, or obtaining venture capital to form a new company
